Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum MERUS LABS INTERNATIONAL INC T.MSL

"Merus Labs International Inc is a specialty pharmaceutical company. The Company acquires and licenses novel pharmaceutical products."

TSX:MSL - Post Discussion

MERUS LABS INTERNATIONAL INC > News: Nasdaq Notice Regarding Min. Bid Price
View:
Comment by campst on Nov 17, 2016 11:26am
I've grown sour on current management and their strategy(?).  While it is not my worst performer, I have difficulty in rationalizing holding. This is good news IMO.  Things (management??) need to be shaken up.  All that is required is a good activist investor..... .....but what do I know? cheers
Comment by Kensin1953 on Nov 17, 2016 2:02pm
It's hard to argue with your logic to have a new strategist for this company.  When you look at the others in this group PLI, GUD, CXR. NHC some that have had much worse news and hard sell offs as well are responding since Trump was voted in. I can't help but have trepidaton over the reaction if they are not profitable this quarter.   The other obvious Goriila is the analysts ...more  
Comment by Trader1972 on Nov 17, 2016 4:09pm
Well Kensin, it all depends of one's patience..... 
Comment by Kensin1953 on Nov 18, 2016 11:53am
Patience is what's left. NHC is up significantly. I notice they make a claim that they will take care of or will address the share price within the de-listing terms of their MSLI agreement. I hope that means beating the projections as NHC has.  JMO
Comment by Trader1972 on Nov 18, 2016 1:37pm
We should all read this in a couple of week or so (last year they posted their year end on December 3rd). So we should expect notice in the next couple of week. Cheers and hang in their! This could be the start of something.....black earning !!!! ;-)
Comment by campst on Nov 18, 2016 2:12pm
Merus has 180 days to get their collective butts in gear. Here is a link which suggests 4 options and I paraphrase: https://thebowserreport.com/financial-news/the-nasdaqs-minimum-bid-price-requirement/ 1) good performance 2) good press 3) reverse split 4) buy backs Number 1 is the only acceptable alternative in the case of Merus..... ....but what do I know? cheers
Comment by Kensin1953 on Nov 18, 2016 8:02pm
Reverse Split is total horse shite. What's out 120m shares?  If they do that they might as well tell the world they are cooked. I'll take door number one and two please. JMO
Comment by lscfa on Nov 29, 2016 10:29am
MSL should voluntarily delist like cipher..... https://www.newswire.ca/news-releases/cipher-pharmaceuticals-announces-plans-to-voluntarily-delist-from-nasdaq-603540606.html
Comment by Spidey2332 on Mar 21, 2017 12:50pm
By choice or not it's the same result. You've been singing the same song for a long time now and I'm sure not the only one bored by you. 170 ignoring you wonder why.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities